Avtor/Urednik | Černič-Šuligoj, Nataša; Zorc, Metka; Grad, Anton; Kar, Saibal; Noč, Marko | |
Naslov | Perkutano zapiranje ovalnega okna - izkušnje z novejšimi tipi zapiral | |
Prevedeni naslov | Percutaneous closure of patent foramen ovale - experience with novel devices | |
Tip | članek | |
Vir | Slov Kardiol | |
Vol. in št. | Letnik 8, št. 1-2 | |
Leto izdaje | 2011 | |
Obseg | str. 13-7 | |
Jezik | slo | |
Abstrakt | Background. Patent foramen ovale (PFO) is a presumed cause of cryptogenic stroke in young adults. To close PFO mostly Amplatz occluder was used for several years, but recently new devices which are smaller and partly bioabsorbable became commercially available. Patients. Consecutive patients with ischemic stroke or transitory ischemic attack (TIA) for which PFO was probable reason. Methods. From September 24, 2007 to December 5, 2010, percutaneous closure of PFO was attempted in 72 patients in the Medical Center Izola. Beside fluoroscopy, transesophageal echocardiography (63 patients) or intracardiac ultrasound (9 patients) was used. 67 patients (93%) were consciously sedated, while 5 patients (7%) had complete general anesthesia. Sizing baloon was used in 89% and the following devices were implanted: Starflex 7 (10%), Biostar 48 (67%), FlatStent 16 (22%), Amplatz PFO occluder 1 (1%). Results. After PFO closure the position and morphology of the device was suitable in 71 patients (99%) and residual shuntwas absent or small (less then 5 bubbles). During a follow-up of 16o+40 days (range 46 to 558 days) 1 patient had a stroke (1%) and 2 patients had TIA (2,8%). In 58 patients control transesophageal echocardiography was performed and no or minimal residual shunt was found in 88%, while there was no case of thrombus on the device. Conclusions. Percutaneus closure of PFO with novel devices like Starflex, Biostar and FlatStent proves to be safe and effective. | |
Deskriptorji | HEART SEPTAL DEFECTS, ATRIAL ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL ECHOCARDIOGRAPHY, TRANSESOPHAGEAL ANGIOPLASTY, BALLOON ADULT |